Previous close | 101.84 |
Open | 102.17 |
Bid | 101.41 x 200 |
Ask | 110.12 x 200 |
Day's range | 101.30 - 102.17 |
52-week range | 75.93 - 104.07 |
Volume | |
Avg. volume | 1,113,604 |
Market cap | 20.166B |
Beta (5Y monthly) | 0.93 |
PE ratio (TTM) | 69.49 |
EPS (TTM) | 1.46 |
Earnings date | 30 May 2024 |
Forward dividend & yield | 0.02 (0.01%) |
Ex-dividend date | 26 July 2023 |
1y target est | 107.79 |
Key Insights Cooper Companies will host its Annual General Meeting on 19th of March Salary of US$1.05m is part of CEO...
SAN RAMON, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Revenue increased 9% year-over-year to $931.6 million. CooperVision (CVI) revenue up 7% to $621.5 million, and CooperSurgical (CSI) revenue up 12% to $310.1 million.GAAP diluted earnings per share (EPS) of $0.41, down $0.02 or 5% from last year's first quarter.Non-GAAP diluted EPS of $0.
The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.